Filtros de búsqueda

Lista de obras de

A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned

artículo científico publicado en 2016

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group

artículo científico publicado en 1995

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection

artículo científico publicado en 2006

A pilot study of low-dose zidovudine in human immunodeficiency virus infection

artículo científico publicado en 1990

A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people

artículo científico publicado en 2006

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

artículo científico publicado en 1990

A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy

artículo científico publicado en 2005

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

artículo científico publicado en 2003

A randomized, double-blind, phase I/II trial of tumor necrosis factor and interferon-gamma for treatment of AIDS-related complex (Protocol 025 from the AIDS Clinical Trials Group).

artículo científico publicado en 1992

AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics

artículo científico publicado en 2008

Abacavir hypersensitivity reaction in primary HIV infection

artículo científico publicado en 2006

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

artículo científico publicado en 2009

Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results

artículo científico publicado en 2011

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people

artículo científico publicado en 2014

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).

artículo científico publicado en 2005

Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy

artículo científico publicado en 1991

Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy

artículo científico publicado en 2001

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

artículo científico publicado en 2015

Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.

artículo científico publicado en 2013

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

artículo científico publicado en 1988

Antiretroviral-drug resistance among patients recently infected with HIV.

artículo científico publicado en 2002

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

artículo científico publicado en 2016

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

artículo científico publicado en 2013

Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group

artículo científico publicado en 2012

Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009

artículo científico publicado en 2013

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood

artículo científico publicado en 1998

Association between cytomegalovirus seroconversion and upper genital tract infection among women attending a sexually transmitted disease clinic: a prospective study

artículo científico publicado en 1998

Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease

artículo científico publicado en 2004

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

artículo científico publicado en 2014

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

artículo científico publicado en 2011

Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333.

artículo científico publicado en 2000

Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals

artículo científico publicado en 2015

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

artículo científico publicado en 2014

Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

scientific article published on 01 October 2019

Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results

artículo científico publicado en 2015

CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies

artículo científico publicado en 2012

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

artículo científico publicado en 2010

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

artículo científico publicado en 2011

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease

artículo científico publicado en 2015

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

artículo científico publicado en 2020

Central nervous system manifestations in human immunodeficiency virus infection without AIDS

artículo científico publicado el 1 de enero de 1992

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

scientific article published on 12 September 2018

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

artículo científico publicado en 2017

Cerebrospinal fluid treponemal antibodies in untreated early syphilis

scientific article published on 01 January 1995

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects

artículo científico publicado en 2019

Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women

scientific article published on 01 January 1995

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy ⬇️

artículo científico publicado el 22 de abril de 2003

Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.

artículo científico publicado en 2012

Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort

artículo científico publicado en 2014

Clinical and epidemiologic features of primary HIV infection

scientific article published on 01 August 1996

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

artículo científico publicado en 1998

Clinical factors related to brain structure in HIV: the CHARTER study

artículo científico publicado en 2011

Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age.

artículo científico publicado en 2002

Clinical validation of the NeuroScreen

artículo científico publicado en 2005

Clinical variables identify seronegative HCV co-infection in HIV-infected individuals

artículo científico publicado en 2011

Cognitive risk factors and neuropsychological performance in HIV infection

artículo científico publicado en 1993

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group

artículo científico publicado en 1995

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection

artículo científico publicado en 1993

Combination therapy with zidovudine, didanosine and saquinavir

scientific article published on 01 January 1996

Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results

artículo científico publicado en 2005

Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women

artículo científico publicado el 19 de octubre de 1984

Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance

artículo científico publicado en 2008

Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney

artículo científico publicado en 2000

Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort

artículo científico publicado en 2013

Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses

artículo científico publicado en 2009

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study

scientific article published on May 2010

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study

scientific article published on 14 June 2019

Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact

scientific article published on 07 October 2020

Cryptosporidiosis after marrow transplantation: person-to-person transmission and treatment with spiramycin

artículo científico publicado en 1984

Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity

artículo científico publicado en 1987

Cytomegalovirus infection in women attending a sexually transmitted disease clinic

artículo científico publicado en 1990

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration

artículo científico publicado en 2012

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

artículo científico publicado en 2007

Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings

artículo científico publicado en 2012

Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes

artículo científico publicado en 2011

Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning

artículo científico publicado en 2011

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

artículo científico publicado en 2017

Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings

artículo científico publicado en 2019

Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?

artículo científico publicado en 2001

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

artículo científico publicado en 2000

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.

artículo científico publicado en 2000

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.

artículo científico publicado en 2013

Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants

artículo científico publicado en 2017

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV ⬇️

artículo científico publicado el 23 de noviembre de 2010

Effect of adjunct hydroxyurea on helper T cell immunity in HIV type 1-infected patients with virological suppression

artículo científico publicado en 2004

Effect of early versus deferred antiretroviral therapy for HIV on survival

artículo científico publicado en 2009

Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysi

artículo científico publicado en 2017

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

artículo científico publicado en 2011

Effects of comorbidity burden and age on brain integrity in HIV

artículo científico publicado en 2019

Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals

artículo científico publicado en 2011

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

artículo científico publicado en 2001

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein

artículo científico publicado en 1993

Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses

artículo científico publicado en 2008

Erratum: Corrigendum: Protective HIV-specific CD8+ T cells evade Treg cell suppression

scholarly article published in Nature Medicine

Etravirine in CSF is highly protein bound

artículo científico publicado en 2013

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

artículo científico publicado en 2016

Evaluation of cerebrospinal fluid in Southeast Asian refugees with reactive serologic tests for syphilis

artículo científico publicado en 1996

Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy ⬇️

artículo científico publicado el 1 de noviembre de 1997

Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy

artículo científico publicado en 2014

Factors associated with remaining on initial randomized efavirenz-containing regimens

artículo científico publicado en 2013

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons

artículo científico publicado en 2011

Fertility parameters in men infected with human immunodeficiency virus

artículo científico publicado en 1991

Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

artículo científico publicado en 2015

Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection

artículo científico publicado en 2004

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.

artículo científico publicado en 2012

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy

artículo científico publicado en 2014

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study

artículo científico publicado en 2017

Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial

artículo científico publicado en 2012

HIV dynamics in seminal plasma during primary HIV infection

artículo científico publicado en 2008

HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status

artículo científico publicado en 2012

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter

artículo científico publicado en 2014

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors ⬇️

artículo científico publicado el 21 de diciembre de 2010

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

artículo científico publicado en 2010

Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity

artículo científico publicado en 2012

Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.

artículo científico publicado en 2018

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

artículo científico publicado en 2012

How often does treatment of primary HIV lead to post-treatment control?

artículo científico publicado en 2015

Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell counts

artículo científico publicado en 1994

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

artículo científico publicado en 2008

Identification of multiple strains of cytomegalovirus in homosexual men

artículo científico publicado en 1989

Identifying the early post-HIV antibody seroconversion period

artículo científico publicado en 2011

Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries

artículo científico publicado en 2014

Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study

artículo científico publicado en 2017

Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202

artículo científico publicado en 2012

Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen

artículo científico publicado en 2017

Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis

artículo científico publicado en 2011

Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis

artículo científico publicado en 2011

Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection

article

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection

artículo científico publicado en 2013

Interference of recombinant soluble CD4 immunoglobulin G in flow cytometric measurement of CD4+ lymphocytes

artículo científico publicado el 1 de febrero de 1992

Intermittent Shedding of Human Immunodeficiency Virus in Semen: Implications for Sexual Transmission ⬇️

artículo científico publicado el 1 de septiembre de 1995

Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy

artículo científico publicado en 2007

Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment

artículo científico publicado en 1988

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013

artículo científico publicado en 2014

Late presentation for human immunodeficiency virus care in the United States and Canada.

artículo científico publicado en 2010

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

artículo científico publicado en 2017

Lifetime suicidal ideation and attempt are common among HIV+ individuals

artículo científico publicado en 2011

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals

artículo científico publicado en 2016

Long-term body composition changes in antiretroviral-treated HIV-infected individuals

artículo científico publicado en 2016

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients

artículo científico publicado en 2015

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

artículo científico publicado en 2010

Low atazanavir concentrations in cerebrospinal fluid

artículo científico publicado en 2009

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation

artículo científico publicado en 2013

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir

artículo científico publicado en 2012

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia

artículo científico publicado en 2015

Lower genitourinary tract sources of seminal HIV

scientific article published on 01 April 2006

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

artículo científico publicado en 2012

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

artículo científico publicado en 1998

Male sex and obesity are associated with residual plasma HIV-1 viremia in persons on long-term antiretroviral therapy

scientific article published on 30 June 2020

Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV.

artículo científico publicado en 2010

Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america

artículo científico publicado en 2011

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection

artículo científico publicado en 2015

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

artículo científico publicado en 2012

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates

artículo científico publicado en 2019

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study

artículo científico publicado en 2014

Neurocognitive impact of substance use in HIV infection

artículo científico publicado en 2011

Neurocognitive impairment in HIV-infected individuals with previous syphilis

artículo científico publicado en 2013

Neurologic Manifestations of HIV Infection Without AIDS:Follow-UP of a Cohort of Homosexual and Bisexual Men

artículo científico publicado en 1996

Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection

artículo científico publicado en 1987

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT ⬇️

artículo científico publicado el 1 de abril de 2011

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

artículo científico publicado en 2011

Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

artículo científico publicado en 2013

P07-06. HIV-1 transmission and early evolution: whole genome analysis

article

Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).

artículo científico publicado en 2015

Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial

article

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

scientific article published on 15 July 2019

Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection

artículo científico publicado en 1991

Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects

artículo científico publicado en 2004

Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal

artículo científico publicado en 1990

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy ⬇️

artículo científico publicado el 1 de noviembre de 1997

Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection.

artículo científico publicado en 1995

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

article

Plasma viremia in human immunodeficiency virus infection

artículo científico publicado en 1989

Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV

artículo científico publicado en 2020

Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy

artículo científico publicado en 2007

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

artículo científico publicado en 2016

Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection

artículo científico publicado en 2011

Prevalence and predictive value of intermittent viremia with combination hiv therapy

artículo científico publicado en 2001

Primary HIV Infection.

artículo científico publicado en 2004

Primary HIV infection education: knowledge and attitudes of HIV-negative men who have sex with men attending a public health sexually transmitted disease clinic

artículo científico publicado en 2006

Prospective cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysis ⬇️

artículo científico publicado el 1 de julio de 1992

Protective HIV-specific CD8+ T cells evade Treg cell suppression

artículo científico publicado en 2011

Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings.

artículo científico publicado en 2018

Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women

artículo científico publicado en 2018

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

article

Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study

artículo científico publicado en 2016

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.

artículo científico publicado en 2008

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

artículo científico publicado en 2010

Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy

artículo científico publicado en 1991

Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.

artículo científico publicado en 2014

Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study

artículo científico publicado en 2010

Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.

artículo científico publicado en 1987

Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

artículo científico publicado en 2012

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons

artículo científico publicado en 2013

Reply to Haddow et al.

artículo científico publicado en 2015

Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.

artículo científico publicado en 1999

Risk factors for HIV-1 shedding in semen

artículo científico publicado en 1999

SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY

artículo científico publicado en 2020

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection ⬇️

artículo científico publicado en 2010

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein ⬇️

artículo científico publicado el 9 de marzo de 1991

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

artículo científico publicado en 2004

Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex

scientific article published on 01 October 1995

Screening and Enrollment by Sex in HIV Clinical Trials in the United States

scientific article published on 29 September 2019

Screening for acute HIV infection: lessons learned

scientific article published on 20 December 2006

Screening for distal sensory peripheral neuropathy in HIV-infected persons in research and clinical settings

artículo científico publicado en 1998

Selection on the human immunodeficiency virus type 1 proteome following primary infection

artículo científico publicado en 2006

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

artículo científico publicado en 2020

Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls

artículo científico publicado en 1995

Seroepidemiologic screening for antibodies to LAV/HTLV-III in Sri Lanka, 1980-1982.

artículo científico publicado en 1985

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.

artículo científico publicado en 2014

Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection

artículo científico publicado en 2011

Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design

artículo científico publicado en 2013

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).

artículo científico publicado en 2007

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

artículo científico publicado en 2018

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements

article

The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia

artículo científico publicado en 1994

The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy

artículo científico publicado en 2013

The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.

artículo científico publicado en 1995

The prevalence and incidence of neurocognitive impairment in the HAART era.

artículo científico publicado en 2007

The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system

artículo científico publicado en 2007

The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.

artículo científico publicado en 1994

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

artículo científico publicado en 1990

Therapeutic amprenavir concentrations in cerebrospinal fluid

artículo científico publicado en 2012

Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal

artículo científico publicado el 1 de enero de 1992

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

scientific article published on 29 July 2019

Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection

artículo científico publicado en 2009

Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.

artículo científico publicado en 2010

Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.

artículo científico publicado en 2018

Treatment of Primary HIV

scientific article published on 01 February 2002

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

artículo científico publicado en 1996

Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

artículo científico publicado en 2001

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection

scientific article published on 22 September 2020

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

artículo científico publicado en 2013

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

artículo científico publicado en 2009

Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial

scientific article published on 06 May 2019

Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.

artículo científico publicado en 1998

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities ⬇️

scientific article published on 02 October 2019

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy

artículo científico publicado en 1998

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

artículo científico publicado en 2008

Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype

artículo científico publicado en 2010

Weight gain following antiretroviral therapy (ART) initiation in ART-naïve people living with HIV in the current treatment era

artículo científico publicado en 2020

White matter damage, neuroinflammation, and neuronal integrity in HAND

artículo científico publicado en 2018

Zidovudine disposition during hemodialysis in a patient with acquired immunodeficiency syndrome

artículo científico publicado en 1990

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

artículo científico publicado en 1993

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda